PRODUCTS

Program Therapeutic Area Development Stage Milestones
Preclinical Phase 1
Phase 2
Randomised Studies Filing Reimbursement
Ruzurgi Neurology
Available via Named Patient Supply Pending
TGA registration September 2021.
Reimbursement Q2 2022
K-Citra Urology
K-Citra Registered
Available since December 2021
ORS003 Hospital Critical Care
Transfer of manufacturer
MA transfer estimated February 2022
ORS004 Oncology
In development
To be advised
ORS005 Antimycobacterial
Final Regulatory preparation for submission
Registration estimated 2023